Literature DB >> 30631112

Considerations for pharmacogenomic testing in a health system.

Roseann S Gammal1,2, Kelly E Caudle3, Teri E Klein4, Mary V Relling3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30631112     DOI： 10.1038/s41436-018-0421-x

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  2 in total

1.  Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.

Authors:  Dianbo Liu; Karen L Olson; Shannon F Manzi; Kenneth D Mandl
Journal:  Genet Med       Date:  2021-01-08       Impact factor: 8.864

Review 2.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.